Loading clinical trials...
Loading clinical trials...
Efficacy of Combined Intense Pulsed Light (IPL) With Fractional Erbium:YAG Laser Ablation in Scar Prevention
The scar site was divided into 3 sites; combined IPL/fractional Er:YAG laser treatment site, fractional Er:YAG laser treatment site and untreated control site. At baseline, three lesions were randomized to IPL / fractional Er:YAG laser combination therapy site, fractional Er:YAG laser treatment alone site, and untreated control site. The laser treatment was conducted total three sessions, immediately at suture removal (baseline), 4 weeks after suture removal and 8 weeks after suture removal. The evaluation of scar site was conducted 3 months later after last treatment (20 weeks after suture removal).
Age
20 - No limit years
Sex
ALL
Healthy Volunteers
No
Kangnam Sacred Heart Hospital
Seoul, South Korea
Start Date
January 6, 2020
Primary Completion Date
November 14, 2021
Completion Date
November 14, 2021
Last Updated
January 26, 2021
30
ESTIMATED participants
fractional Er:YAG laser
DEVICE
Intense pulse light
DEVICE
Lead Sponsor
Hallym University Kangnam Sacred Heart Hospital
NCT00892723
NCT00811577
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions